Nemus Bioscience (NMUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NMUS | AMGN | GILD | VRTX | BIIB |
| Company | Nemus Bioscience | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic | Biogen Inc |
| Price Information | |||||
| Exchange | OTC US | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.7185 | 264.63 | 66.25 | 394.72 | 190.72 |
| High | 0.7189 | 265.59 | 66.72 | 396.98 | 191.73 |
| Low | 0.6000 | 260.68 | 66.16 | 393.00 | 189.44 |
| Last | 0.6500 | 265.05 | 66.50 | 395.54 | 190.99 |
| Change | -0.0684 | +2.30 | +0.34 | +2.06 | +0.47 |
| % Change | -9.52% | +0.88% | +0.51% | +0.52% | +0.25% |
| Volume | 1,004,500 | 472,764 | 1,711,135 | 226,749 | 239,562 |
| 20-Day Average Volume | 494,515 | 2,097,141 | 5,967,913 | 873,067 | 1,069,173 |
| Previous Close | 0.7184 | 262.75 | 66.16 | 393.48 | 190.52 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.5046 | 272.32 | 69.88 | 405.60 | 204.86 |
| 20-Day Raw Stochastic | 72.67% | 12.19% | 6.90% | 16.15% | 4.69% |
| 20-Day Relative Strength | 63.72% | 38.37% | 29.59% | 39.45% | 27.57% |
| Weighted Alpha | +34.72 | +4.99 | -24.81 | +16.62 | -38.55 |
| Today's Opinion | 100% Buy | 56% Sell | 100% Sell | 8% Buy | 100% Sell |
| Previous Opinion | 100% Buy | 56% Sell | 100% Sell | 8% Buy | 100% Sell |
| Last Month's Opinion | 88% Buy | 8% Sell | 72% Sell | 40% Buy | 100% Sell |
| Performance | |||||
| 5-Days | |||||
| %Chg | +40.54% since 03/15/19 | -1.20% since 04/12/24 | -2.38% since 04/12/24 | -0.16% since 04/12/24 | -3.66% since 04/12/24 |
| Low | 0.4700 on 03/18/19 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.7440 on 03/21/19 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 402.49 on 04/15/24 | 199.53 on 04/15/24 |
| 1-Month | |||||
| %Chg | +31.31% since 02/22/19 | -2.82% since 03/19/24 | -9.48% since 03/19/24 | -4.64% since 03/19/24 | -12.67% since 03/19/24 |
| Low | 0.4000 on 03/11/19 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.7440 on 03/21/19 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 421.45 on 04/01/24 | 221.74 on 03/21/24 |
| 3-Month | |||||
| %Chg | +62.54% since 12/21/18 | -14.21% since 01/19/24 | -23.87% since 01/19/24 | -8.99% since 01/19/24 | -23.61% since 01/19/24 |
| Low | 0.3000 on 01/31/19 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 391.01 on 04/18/24 | 189.44 on 04/19/24 |
| High | 0.7440 on 03/21/19 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 448.40 on 01/30/24 | 252.17 on 01/22/24 |
| 6-Month | |||||
| %Chg | +120.34% since 09/21/18 | -5.89% since 10/19/23 | -15.29% since 10/19/23 | +8.53% since 10/19/23 | -25.79% since 10/19/23 |
| Low | 0.0500 on 10/31/18 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 341.90 on 11/16/23 | 189.44 on 04/19/24 |
| High | 0.7440 on 03/21/19 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 448.40 on 01/30/24 | 268.30 on 01/03/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 87,040 | 140,812,720 | 82,374,304 | 101,698,464 | 27,694,178 |
| Shares Outstanding, K | 133,908 | 535,919 | 1,245,077 | 258,459 | 145,361 |
| Annual Sales | 0 | 28,190,000,000 | 27,116,000,000 | 9,869,200,000 | 9,835,600,000 |
| Annual Net Income | -19,190,000 | 6,717,000,000 | 5,665,000,000 | 3,619,600,000 | 1,161,100,000 |
| Last Quarter Sales | 0 | 8,196,000,000 | 7,114,000,000 | 2,517,700,000 | 2,386,300,000 |
| Last Quarter Net Income | -6,220,000 | 767,000,000 | 1,429,000,000 | 968,800,000 | 249,700,000 |
| 60-Month Beta | -0.04 | 0.58 | 0.19 | 0.35 | -0.02 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 4.20 on 02/05/24 | 2.95 on 02/13/24 |
| Latest Earnings Date | 10/05/18 | 05/02/24 | 04/25/24 | 05/06/24 | 04/24/24 |
| Most Recent Dividend | N/A | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 05/16/24 | 03/14/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.16 | 9.96 | 29.25 | 13.05 |